🔎 Trials Near Me

Akèy › Kansè nan tete › Lwizyàn › Shreveport

Etid klinik pou Kansè nan tete nan Shreveport, LA

8 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Shreveport (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Ap rekriteFaz 3
  • Willis-Knighton Cancer Center, Shreveport
Laj 18 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT05827081

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Ap rekriteFaz 2
  • LSU Health Sciences Center, Shreveport
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07102381

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Ap rekriteFaz 3
  • Louisiana State University Health Sciences Shreveport ( Site 0053), Shreveport
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06966700

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Ap rekrite
  • Willis Knighton Cancer Center, Shreveport
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07214532

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Ap rekriteFaz 3
  • LSU Health Sciences Center at Shreveport, Shreveport
  • CHRISTUS Highland Medical Center, Shreveport
  • Ochsner LSU Health - Cancer Treatment Center, Shreveport
Laj 18 a 60 · Fanm · Mizajou Sep 2, 2026 · NCT05879926

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Ap rekriteFaz 3
  • LSU Health Sciences Center at Shreveport, Shreveport
  • Ochsner LSU Health - Cancer Treatment Center, Shreveport
Laj 50 a 70 · Tout sèks · Mizajou Apr 23, 2026 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Ap rekriteEtid obsèvasyon
  • LSU Health Sciences Center at Shreveport, Shreveport
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Ap rekriteEtid obsèvasyon
  • Louisiana State University, Shreveport
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2025 · NCT03053193

Etid Kansè nan tete nan lòt vil

Lòt etid nan Shreveport

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.